{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:36:01Z","timestamp":1790480161692,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC96-2314-B075- 0720-MY3"],"award-info":[{"award-number":["NSC96-2314-B075- 0720-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["VGH97C1-092"],"award-info":[{"award-number":["VGH97C1-092"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["VGH98C1-114"],"award-info":[{"award-number":["VGH98C1-114"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["VGH97C1-063"],"award-info":[{"award-number":["VGH97C1-063"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejca.2012.04.015","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T04:30:41Z","timestamp":1339648241000},"page":"3465-3474","source":"Crossref","is-referenced-by-count":12,"title":["Gemcitabine causes telomere attrition by stabilizing TRF2"],"prefix":"10.1016","volume":"48","author":[{"given":"Chih-Hao","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chih","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng-Hsin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl. 11","key":"10.1016\/j.ejca.2012.04.015_b0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/sonc.2002.34055","article-title":"Gemcitabine and targeted therapy in metastatic breast cancer","volume":"29","author":"Qu","year":"2002","journal-title":"Semin Oncol"},{"issue":"3 Suppl. 9","key":"10.1016\/j.ejca.2012.04.015_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/sonc.2002.34277","article-title":"Gemcitabine induction chemotherapy in non-small cell lung cancer","volume":"29","author":"Depierre","year":"2002","journal-title":"Semin Oncol"},{"issue":"3 Suppl. 9","key":"10.1016\/j.ejca.2012.04.015_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/sonc.2002.34269","article-title":"Present and future treatment of pancreatic cancer","volume":"29","author":"Heinemann","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2012.04.015_b0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000421-200008000-00007","article-title":"Phase I study of paclitaxel and day 1\/day 8 gemcitabine in patients with solid malignancies","volume":"23","author":"Fleming","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.04.015_b0025","first-page":"6075","article-title":"Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity","volume":"60","author":"Rauchwerger","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.04.015_b0030","first-page":"4582","article-title":"Effect of a template-located 2\u2032, 2\u2032-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3\u2032\u21925\u2032exonuclease) fragment","volume":"53","author":"Schy","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.04.015_b0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0006-2952(94)90554-1","article-title":"Schedule dependence of sensitivity to 2\u2032, 2\u2032-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours","volume":"48","author":"Ruiz van Haperen","year":"1994","journal-title":"Biochem Pharmacol"},{"issue":"4 Suppl. 11","key":"10.1016\/j.ejca.2012.04.015_b0040","first-page":"11","article-title":"Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism","volume":"22","author":"Heinemann","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2012.04.015_b0045","first-page":"533","article-title":"Cellular elimination of 2\u2032,2\u2032-difluorodeoxycytidine 5\u2032-triphosphate: a mechanism of self-potentiation","volume":"52","author":"Heinemann","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.04.015_b0050","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/jm00110a019","article-title":"2\u2032-Deoxy-2\u2032-methylenecytidine and 2\u2032-deoxy-2\u2032, 2\u2032-difluorocytidine 5\u2032-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase","volume":"34","author":"Baker","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejca.2012.04.015_b0055","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1126\/science.270.5242.1601","article-title":"Telomeres: beginning to understand the end","volume":"270","author":"Zakian","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejca.2012.04.015_b0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"350","author":"Blackburn","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2012.04.015_b0065","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2012.04.015_b0070","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1073\/pnas.86.18.7049","article-title":"Conservation of the human telomere sequence (TTAGGG)n among vertebrates","volume":"86","author":"Meyne","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2012.04.015_b0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.ge.23.120189.003051","article-title":"Structure and function of telomeres","volume":"23","author":"Zakian","year":"1989","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.ejca.2012.04.015_b0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/MCB.10.2.518","article-title":"Structure and variability of human chromosome ends","volume":"10","author":"de Lange","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2012.04.015_b0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(89)90035-4","article-title":"The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats","volume":"59","author":"Morin","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2012.04.015_b0090","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/j.1460-2075.1992.tb05245.x","article-title":"Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity","volume":"11","author":"Counter","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2012.04.015_b0095","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejca.2012.04.015_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nm0395-249","article-title":"Correlating telomerase activity levels with human neuroblastoma outcomes","volume":"1","author":"Hiyama","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2012.04.015_b0105","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1073\/pnas.91.8.2900","article-title":"Telomerase activity in human ovarian carcinoma","volume":"91","author":"Counter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2012.04.015_b0110","first-page":"4052","article-title":"Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis","volume":"58","author":"Tang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.04.015_b0115","doi-asserted-by":"crossref","first-page":"R901","DOI":"10.1016\/j.cub.2004.09.075","article-title":"Telomere biology: a new player in the end zone","volume":"14","author":"Colgin","year":"2004","journal-title":"Current Biology"},{"key":"10.1016\/j.ejca.2012.04.015_b0120","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/MCB.20.5.1659-1668.2000","article-title":"Control of human telomere length by TRF1 and TRF2","volume":"20","author":"Smogorzewska","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2012.04.015_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.biochem.73.071403.160049","article-title":"Regulation of telomerase by telomeric proteins","volume":"73","author":"Smogorzewska","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejca.2012.04.015_b0130","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1073\/pnas.83.16.5889","article-title":"Affinity purification of sequence-specific DNA binding proteins","volume":"83","author":"Kadonaga","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2012.04.015_b0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/11532970-000000000-00000","article-title":"Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms","volume":"49","author":"Sugiyama","year":"2010","journal-title":"J Clin Pharmacokinet"},{"key":"10.1016\/j.ejca.2012.04.015_b0140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ng1633","article-title":"XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer","volume":"37","author":"Mu\u00f1oz","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2012.04.015_b0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.dnarep.2006.03.012","article-title":"TERF2-XPF: caught in the middle; beginnings from the end","volume":"5","author":"McDaniel","year":"2006","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ejca.2012.04.015_b0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1101\/gad.406207","article-title":"Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis","volume":"21","author":"Blanco","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejca.2012.04.015_b0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1535-7163.MCT-07-2122","article-title":"Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model","volume":"7","author":"Laquente","year":"2008","journal-title":"Mol Cancer Ther"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912003668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912003668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T03:55:55Z","timestamp":1588823755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912003668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0959804912003668"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.04.015","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}